UiPath Inc. (NYSE:PATH - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Investors bought 22,720 call options on the stock. This represents an increase of 32% compared to the typical daily volume of 17,204 call options.
UiPath Trading Up 2.6%
PATH stock traded up $0.34 during mid-day trading on Friday, hitting $13.28. 47,371,291 shares of the company were exchanged, compared to its average volume of 10,666,374. UiPath has a 1-year low of $9.38 and a 1-year high of $15.93. The stock has a market capitalization of $7.32 billion, a PE ratio of -83.00 and a beta of 1.01. The business has a 50 day simple moving average of $11.53 and a 200-day simple moving average of $12.69.
UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. The business had revenue of $356.62 million during the quarter, compared to analysts' expectations of $332.17 million. UiPath had a negative return on equity of 4.14% and a negative net margin of 6.49%. The firm's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $0.13 EPS. Equities research analysts expect that UiPath will post -0.17 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Morgan Stanley reduced their price objective on shares of UiPath from $16.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday, March 13th. Bank of America reissued an "underperform" rating and set a $10.00 price target (down from $18.00) on shares of UiPath in a research report on Thursday, March 13th. DA Davidson boosted their price target on UiPath from $11.00 to $14.00 and gave the stock a "neutral" rating in a research report on Friday. Needham & Company LLC reiterated a "hold" rating on shares of UiPath in a research note on Friday. Finally, Canaccord Genuity Group cut their price objective on UiPath from $19.00 to $14.00 and set a "buy" rating for the company in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $13.41.
View Our Latest Stock Analysis on UiPath
Insiders Place Their Bets
In other news, CFO Ashim Gupta sold 98,795 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the sale, the chief financial officer now owns 987,322 shares of the company's stock, valued at $11,857,737.22. The trade was a 9.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Hitesh Ramani sold 12,500 shares of the stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total transaction of $127,375.00. Following the transaction, the chief accounting officer now owns 314,891 shares of the company's stock, valued at $3,208,739.29. The trade was a 3.82% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 23.19% of the company's stock.
Institutional Investors Weigh In On UiPath
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Acadian Asset Management LLC grew its stake in shares of UiPath by 222.6% in the first quarter. Acadian Asset Management LLC now owns 4,241,047 shares of the company's stock valued at $43,667,000 after acquiring an additional 2,926,263 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in UiPath by 5.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,477,730 shares of the company's stock valued at $15,221,000 after purchasing an additional 75,737 shares during the period. Woodline Partners LP grew its position in shares of UiPath by 69.6% during the 1st quarter. Woodline Partners LP now owns 22,566 shares of the company's stock worth $232,000 after purchasing an additional 9,257 shares in the last quarter. Great Lakes Advisors LLC bought a new position in shares of UiPath during the first quarter worth approximately $3,165,000. Finally, Voleon Capital Management LP acquired a new stake in shares of UiPath in the first quarter valued at approximately $437,000. Institutional investors and hedge funds own 62.50% of the company's stock.
About UiPath
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.